Dannae Brown

445 total citations
8 papers, 158 citations indexed

About

Dannae Brown is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Dannae Brown has authored 8 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in Dannae Brown's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and HIV-related health complications and treatments (4 papers). Dannae Brown is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and HIV-related health complications and treatments (4 papers). Dannae Brown collaborates with scholars based in United States, Argentina and United Kingdom. Dannae Brown's co-authors include Mark Underwood, Michael Aboud, Marcelo Losso, Richard Kaplan, Carlos Brites, Jörg Sievers, José A. Hidalgo, Johannes Lombaard, Martin Gartland and Ploenchan Chetchotisakd and has published in prestigious journals such as The Lancet Infectious Diseases, AIDS Research and Human Retroviruses and Journal of the International AIDS Society.

In The Last Decade

Dannae Brown

8 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dannae Brown United States 6 152 118 32 26 10 8 158
Arvind Kaimal Uganda 4 137 0.9× 104 0.9× 32 1.0× 15 0.6× 6 0.6× 6 152
Ainoa Ugarte Spain 6 86 0.6× 58 0.5× 29 0.9× 36 1.4× 7 0.7× 21 117
Johannes Lombaard United States 2 106 0.7× 85 0.7× 19 0.6× 20 0.8× 9 0.9× 4 110
Natasja van Holten Netherlands 3 132 0.9× 88 0.7× 26 0.8× 44 1.7× 5 0.5× 4 143
J.-G. Baril Canada 4 236 1.6× 186 1.6× 49 1.5× 53 2.0× 25 2.5× 4 254
Pedro Cahn Argentina 4 154 1.0× 126 1.1× 17 0.5× 35 1.3× 7 0.7× 5 169
Shanker Thiagarajah United States 4 132 0.9× 91 0.8× 35 1.1× 19 0.7× 4 0.4× 5 143
Ndèye Méry Dia Badiane Senegal 6 147 1.0× 123 1.0× 35 1.1× 8 0.3× 13 1.3× 16 167
Anthony Scarsella United States 6 127 0.8× 97 0.8× 33 1.0× 40 1.5× 12 1.2× 7 153
Anja Hüfner Germany 8 68 0.4× 80 0.7× 51 1.6× 17 0.7× 7 0.7× 10 137

Countries citing papers authored by Dannae Brown

Since Specialization
Citations

This map shows the geographic impact of Dannae Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dannae Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dannae Brown more than expected).

Fields of papers citing papers by Dannae Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dannae Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dannae Brown. The network helps show where Dannae Brown may publish in the future.

Co-authorship network of co-authors of Dannae Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Dannae Brown. A scholar is included among the top collaborators of Dannae Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dannae Brown. Dannae Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
3.
Aboud, Michael, Richard Kaplan, Johannes Lombaard, et al.. (2019). Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study. Journal of Infection and Public Health. 12(1). 107–107. 5 indexed citations
4.
Demarest, James F., Mark Underwood, Marty St. Clair, et al.. (2018). Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance. AIDS Research and Human Retroviruses. 34(4). 343–346. 16 indexed citations
5.
Vannappagari, Vani, Leigh Ragone, Cassidy Henegar, et al.. (2018). Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. 24(6). 393–404. 13 indexed citations
6.
7.
Bloch, Mark, Norman Roth, Robert Finlayson, et al.. (2017). A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes. International Journal of STD & AIDS. 29(3). 300–305. 7 indexed citations
8.
Cahn, Pedro, Jaime Andrade‐Villanueva, Carlos Beltrán, et al.. (2015). P032: Dolutegravir versus raltegravir in ARV-experienced INI-naïve HIV+ adults: 48-week subgroup analysis of Latin American subjects in the SAILING study. Journal of the International AIDS Society. 18(3 (Suppl 2)). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arvind Kaimal Breakdown of academic impact, for papers by Ainoa Ugarte Breakdown of academic impact, for papers by Johannes Lombaard Breakdown of academic impact, for papers by Natasja van Holten Breakdown of academic impact, for papers by J.-G. Baril Breakdown of academic impact, for papers by Pedro Cahn Breakdown of academic impact, for papers by Shanker Thiagarajah Breakdown of academic impact, for papers by Ndèye Méry Dia Badiane Breakdown of academic impact, for papers by Anthony Scarsella Breakdown of academic impact, for papers by Anja Hüfner
Rankless by CCL
2026